The black mamba is sub-Saharan Africa's longest venomous snake and one of the continent's most widely misunderstood reptiles. Fast, alert, and elusive, it is far more inclined to retreat than to confront, yet its potent neurotoxic venom places it at the center of an important public-health story: snakebite envenoming, which the World Health Organization classifies as a priority Neglected Tropical Disease [WHO 2023]. This profile examines the species' biology, ecological role, and the medical and conservation context surrounding it — distinguishing accurate understanding from the fear-driven myths that have long shadowed this animal.
Biology and Identification
Formally described by Albert Günther in 1864, the black mamba (Dendroaspis polylepis) is the longest venomous snake in Africa and the second-longest in the world after the king cobra. Mature individuals typically exceed 2 m and commonly reach about 3 m; exceptional specimens of 4.3–4.5 m have been reported [Branch et al. 2021]. Despite the name, the snake's body is not black but olive, grayish-brown, gunmetal, or khaki. The "black" refers to the inky-dark lining of the mouth, which the snake gapes as a defensive display when cornered.
The black mamba is among the fastest-moving snakes, but popular accounts greatly exaggerate its pace; documented speed does not exceed roughly 20 km/h (12 mph) over short, level distances [Branch et al. 2021]. It is both terrestrial and semi-arboreal, sheltering in termite mounds, hollow trees, rock crevices, and abandoned burrows, and it tends to return to a fixed lair. Diurnal and visually acute, it hunts actively for small mammals — including hyraxes, bushbabies, and rodents — as well as birds and their nestlings. After striking, the snake typically releases larger prey and waits for the rapid-acting venom to take effect before swallowing it whole [Branch et al. 2021].
The venom is dominated by two families of small proteins: dendrotoxins, which block voltage-gated potassium channels, and three-finger toxins — including α-neurotoxins that block postsynaptic neuromuscular receptors and account for much of its acute toxicity [Laustsen et al. 2015]. These molecules have also made the venom a subject of biomedical research: mambalgin peptides isolated from it inhibit acid-sensing ion channels and produce potent analgesia in animal models, driving interest in non-opioid pain therapeutics [Diochot et al. 2012].
Habitat and Range
The black mamba is broadly distributed across sub-Saharan Africa. Confirmed range spans much of eastern and southern Africa — among them Ethiopia, Somalia, Kenya, Tanzania, the Democratic Republic of the Congo, Zambia, Mozambique, Zimbabwe, Botswana, Namibia, Angola, and South Africa — with reports extending into parts of the Sahel and West Africa, though some western records remain disputed [Branch et al. 2021]. It favors moderately dry, open habitats: savanna, lowland forest edges, rocky hills, and woodland mosaics, generally avoiding true desert and dense closed-canopy rainforest.
Because it often occupies the same termitaria, rock outcrops, and field margins used by people and livestock, the black mamba frequently lives close to rural and agricultural communities — a proximity that has shaped both its reputation and its relevance to public health.
In accordance with NRWL sensitive-species policy, specific site locations, den sites, and seasonal movement details are not disclosed in this article.
Conservation Status
The black mamba is assessed as Least Concern on the IUCN Red List [Branch et al. 2021]. The classification reflects the species' very large geographic range across sub-Saharan Africa, its presence in numerous protected areas, and the absence of evidence for a population decline severe enough to warrant a threatened category. No global population estimate exists, but the species is considered widespread and locally common across much of its range [Branch et al. 2021].
The black mamba is not listed on any CITES Appendix; no member of the genus Dendroaspis appears on the CITES Appendices, meaning international commercial trade in the species is not regulated under that convention [ADW 2014]. A Least Concern listing should not be read as an absence of pressure: localized threats exist, and the species' role in snakebite envenoming makes it a focus of human–wildlife coexistence and public-health planning rather than of species-survival concern.
Threats
The black mamba is not globally threatened, but it faces pressures that are largely local and human-driven. Persecution is foremost: snakes encountered near homes, schools, and farms are frequently killed out of fear, and the species' reputation makes it a particular target [Branch et al. 2021]. Habitat conversion — clearing of savanna and woodland for agriculture and settlement — reduces shelter and prey in some regions, even as edge habitats can locally suit the species.
A distinctive dimension of the black mamba's relationship with people is snakebite envenoming, which runs in both directions. Encounters near human settlements raise the snake's mortality through retaliatory killing. For people, bites — though uncommon relative to other African snakes — can be medically severe and contribute to the broader burden that the WHO recognizes as a Neglected Tropical Disease responsible for tens of thousands of deaths and many more disabilities worldwide each year [WHO 2023; GBD Snakebite 2022]. Sub-Saharan Africa alone is estimated to experience hundreds of thousands of envenomings annually [Chippaux 2011]. Antivenom remains the only specific treatment, yet its supply, affordability, and quality across rural Africa remain inadequate [Habib et al. 2016].
What Is Being Done
Global snakebite strategy. In 2017 the WHO reinstated snakebite envenoming as a priority Neglected Tropical Disease, and in 2019 it launched a strategy aiming to halve snakebite deaths and disability by 2030 through stronger health systems, better antivenom access, and community engagement [WHO 2023; Williams et al. 2019]. This work treats venomous snakes such as the black mamba as part of the landscape to be managed through coexistence rather than eradication.
Antivenom and treatment science. Research on black mamba venom has clarified which toxins antivenoms must neutralize, supporting development of more effective, better-targeted products — including efforts toward recombinant and broadly cross-reactive antivenoms for African snakes [Laustsen et al. 2015].
Access and affordability. Health-economic analyses show that improving antivenom supply across African nations is cost-effective, strengthening the case for sustained investment in rural envenoming care [Habib et al. 2016].
Coexistence and education. Across the species' range, trained snake responders and relocation programs reduce both human risk and the killing of snakes, while community education replaces sensational myths with accurate guidance on first aid and prompt hospital treatment.
How Readers Can Help
Support snakebite-care initiatives. Snakebite envenoming is chronically underfunded relative to its toll. Supporting organizations and research that improve antivenom access in affected regions directly reduces death and disability.
Choose accurate information over fear. Share science-based facts about snakes and the importance of seeking immediate medical care after any bite. Correcting myths reduces both unnecessary killing of snakes and dangerous delays in treatment.
Encourage humane responses. Where snakes enter human spaces, support trained removal-and-relocation services rather than killing. These programs protect people and wildlife alike.
Engage on policy. Back conservation of African savanna and woodland habitats and national commitments under the WHO snakebite strategy. Healthy ecosystems and well-resourced rural health systems both serve human–wildlife coexistence.
Contribute to citizen science. Log reptile observations through platforms such as iNaturalist. Verified records improve range maps and inform conservation assessments and snakebite-risk planning.
References
[ADW 2014] Animal Diversity Web. (2014). Dendroaspis polylepis (Black Mamba) — Conservation status (No special status; not CITES-listed). University of Michigan Museum of Zoology. https://animaldiversity.org/accounts/Dendroaspis_polylepis/
[Branch et al. 2021] Branch, W.R., Trape, J.-F., Luiselli, L., Spawls, S., Penner, J., Howell, K., Msuya, C.A. & Ngalason, W. (2021). Dendroaspis polylepis. The IUCN Red List of Threatened Species 2021: e.T177584A15627370. https://doi.org/10.2305/IUCN.UK.2021-2.RLTS.T177584A15627370.en
[Chippaux 2011] Chippaux, J.-P. (2011). Estimate of the burden of snakebites in sub-Saharan Africa: A meta-analytic approach. Toxicon, 57(4), 586–599. https://doi.org/10.1016/j.toxicon.2011.01.004
[Diochot et al. 2012] Diochot, S., Baron, A., Salinas, M., Douguet, D., Scarzello, S., Dabert-Gay, A.-S., Debayle, D., Friend, V., Alloui, A., Lazdunski, M. & Lingueglia, E. (2012). Black mamba venom peptides target acid-sensing ion channels to abolish pain. Nature, 490, 552–555. https://doi.org/10.1038/nature11494
[GBD Snakebite 2022] GBD 2019 Snakebite Envenomation Collaborators. (2022). Global mortality of snakebite envenoming between 1990 and 2019. Nature Communications, 13, 6160. https://doi.org/10.1038/s41467-022-33627-9
[Habib et al. 2016] Habib, A.G., Lamorde, M., Dalhat, M.M., Habib, Z.G. & Kuznik, A. (2016). Cost-effectiveness of antivenoms for snakebite envenoming in 16 countries in West Africa. PLOS Neglected Tropical Diseases, 9(1), e0004568. https://doi.org/10.1371/journal.pntd.0004568
[Laustsen et al. 2015] Laustsen, A.H., Lomonte, B., Lohse, B., Fernández, J. & Gutiérrez, J.M. (2015). Unveiling the nature of black mamba (Dendroaspis polylepis) venom through venomics and antivenom immunoprofiling: Identification of key toxin targets for antivenom development. Journal of Proteomics, 119, 126–142. https://doi.org/10.1016/j.jprot.2015.02.014
[WHO 2023] World Health Organization. (2023). Snakebite envenoming (Fact sheet). WHO Department of Control of Neglected Tropical Diseases. https://www.who.int/news-room/fact-sheets/detail/snakebite-envenoming
[Williams et al. 2019] Williams, D.J., Faiz, M.A., Abela-Ridder, B., Ainsworth, S., Bulfone, T.C., Nickerson, A.D., Habib, A.G., Junghanss, T., Fan, H.W., Turner, M., Harrison, R.A. & Warrell, D.A. (2019). Strategy for a globally coordinated response to a priority neglected tropical disease: Snakebite envenoming. PLOS Neglected Tropical Diseases, 13(2), e0007059. https://doi.org/10.1371/journal.pntd.0007059